SQUAWK/NEWS
Menu
Live News REGULATION L impact

PEN Penumbra reports THUNDER study results for THUNDERBOLT stroke device Penumbra released THUNDER IDE study results for its THUNDERBOLT Com

PEN Penumbra reports THUNDER study results for THUNDERBOLT stroke device Penumbra released THUNDER IDE study results for its THUNDERBOLT Computer-assisted vacuum thrombectomy system in ELVO stroke. Study met its performance goal, with 87.5% achieving successful reperfusion (mTICI 2B-3); first-pass success was 64.8%. Median time to revascularization was 20 minutes; serious device or procedure-related adverse events were 2.8%. Penumbra said THUNDERBOLT has received US FDA clearance and a CE Mark.

CEIDE

PEN Penumbra reports THUNDER study results for THUNDERBOLT stroke device Penumbra released THUNDER IDE study results for its THUNDERBOLT Computer-assisted vacuum thrombectomy system in ELVO stroke.

Study met its performance goal, with 87.5% achieving successful reperfusion (mTICI 2B-3); first-pass success was 64.8%.

Median time to revascularization was 20 minutes; serious device or procedure-related adverse events were 2.8%.

Penumbra said THUNDERBOLT has received US FDA clearance and a CE Mark.